Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | NMRA |
---|---|---|
09:32 ET | 1677 | 13.19 |
09:36 ET | 8805 | 12.91 |
09:38 ET | 5023 | 13 |
09:39 ET | 1202 | 13.01 |
09:43 ET | 200 | 13 |
09:45 ET | 1200 | 12.98 |
09:48 ET | 1100 | 12.92 |
09:52 ET | 670 | 12.77 |
09:56 ET | 3903 | 13 |
09:57 ET | 600 | 13 |
10:01 ET | 12902 | 13.06 |
10:03 ET | 4063 | 13.06 |
10:06 ET | 850 | 13.06 |
10:08 ET | 3563 | 13.015 |
10:10 ET | 7552 | 12.98 |
10:12 ET | 2450 | 12.995 |
10:14 ET | 100 | 13 |
10:15 ET | 3839 | 13.02 |
10:17 ET | 3412 | 13.06 |
10:19 ET | 900 | 13.07 |
10:21 ET | 800 | 13.07 |
10:24 ET | 553 | 13.06 |
10:26 ET | 1472 | 12.98 |
10:28 ET | 2050 | 13 |
10:30 ET | 3052 | 12.99 |
10:32 ET | 845 | 13.01 |
10:33 ET | 4169 | 13.09 |
10:37 ET | 100 | 13.08 |
10:39 ET | 1208 | 13.09 |
10:44 ET | 1100 | 13.14 |
10:46 ET | 200 | 13.125 |
10:48 ET | 1032 | 13.12 |
10:50 ET | 1100 | 13.12 |
10:51 ET | 3935 | 13.12 |
10:53 ET | 1297 | 13.165 |
10:55 ET | 1000 | 13.14 |
10:57 ET | 912 | 13.12 |
11:00 ET | 1201 | 13.08 |
11:02 ET | 599 | 13.05 |
11:04 ET | 400 | 13.05 |
11:06 ET | 4491 | 13.09 |
11:08 ET | 600 | 13.08 |
11:09 ET | 1900 | 13.11 |
11:11 ET | 300 | 13.12 |
11:13 ET | 600 | 13.11 |
11:15 ET | 500 | 13.11 |
11:18 ET | 1100 | 13.11 |
11:20 ET | 3900 | 13.14 |
11:22 ET | 1325 | 13.17 |
11:24 ET | 200 | 13.18 |
11:26 ET | 2902 | 13.16 |
11:27 ET | 4371 | 13.16 |
11:29 ET | 2799 | 13.18 |
11:31 ET | 100 | 13.18 |
11:33 ET | 400 | 13.195 |
11:38 ET | 1800 | 13.21 |
11:40 ET | 400 | 13.17 |
11:42 ET | 200 | 13.17 |
11:44 ET | 1516 | 13.18 |
11:47 ET | 100 | 13.195 |
11:49 ET | 100 | 13.18 |
11:51 ET | 468 | 13.17 |
11:54 ET | 100 | 13.17 |
11:56 ET | 400 | 13.16 |
11:58 ET | 242 | 13.16 |
12:00 ET | 4510 | 13.22 |
12:02 ET | 428 | 13.24 |
12:03 ET | 100 | 13.23 |
12:05 ET | 2683 | 13.2 |
12:07 ET | 2408 | 13.21 |
12:09 ET | 6046 | 13.23 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Neumora Therapeutics Inc | 2.1B | -8.0x | --- |
Keros Therapeutics Inc | 2.1B | -11.1x | --- |
Akero Therapeutics Inc | 2.0B | -8.4x | --- |
Centessa Pharmaceuticals PLC | 2.0B | -10.6x | --- |
Celldex Therapeutics Inc | 2.2B | -11.8x | --- |
Verona Pharma PLC | 2.2B | -18.6x | --- |
Neumora Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company’s therapeutic pipeline consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its advanced product candidate, navacaprant (NMRA-140), is a novel once-daily oral kappa opioid receptor (KOR) antagonist that is being developed for the treatment of depressive disorder (MDD). Its other candidates include NMRA-266, NMRA-511, and NMRA-NMDA. NMRA-266 is a positive allosteric modulator program of the M4 muscarinic receptor (M4R) for the treatment of schizophrenia. NMRA-266 is designed to be selective for the M4 receptor subtype of the muscarinic receptor family. NMRA-511 is an investigational antagonist of the vasopressin 1a receptor (V1aR). NMRA-NMDA is an NMDA positive allosteric modulator program that the Company is developing for the treatment of schizophrenia.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.1B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 160.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.66 |
Book Value | $2.95 |
P/E Ratio | -8.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.